11.4 Prostaglandins (139)

Showing records 1 to 25

Display all abstracts in classification 11.4 Prostaglandins

Search within classification 11.4 Prostaglandins
80713 Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
Hayashi K
American Journal of Ophthalmology 2019; 205: 91-98
81286 Assessment of the optic nerve head, peripapillary, and macular microcirculation in the newly diagnosed patients with primary open-angle glaucoma treated with topical tafluprost and tafluprost/timolol fixed combination
Kurysheva NI
Taiwan journal of ophthalmology 2019; 9: 93-99
80738 Decreased orbital fat and enophthalmos due to bimatoprost: Quantitative analysis using magnetic resonance imaging
Higashiyama T
PLoS ONE 2019; 14: e0214065
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M
Journal of Glaucoma 2019; 28: 375-385
80749 Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma
Brown GC
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 145-160
80850 Randomized crossover trial comparing effectiveness and tolerability of generic and brand-name travoprost
Ta Kim D
Canadian Journal of Ophthalmology 2019; 54: 223-228
80765 Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
Lopes NLV
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 52-56
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698
81242 Latanoprost treatment differentially affects intraocular pressure readings obtained with three different tonometers
Sánchez-Barahona C
Acta Ophthalmologica 2019; 0:
80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Rossi GCM
Scientific reports 2019; 9: 4282
81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Lee SY
PLoS ONE 2019; 14: e0218886
80766 A case of latanoprost-induced diffuse facial skin hyperpigmentation
Kim HY
Journal of cosmetic dermatology 2019; 0:
81437 Efficacy of travoprost for the treatment of patients with glaucoma
Zhang XL
Medicine 2019; 98: e16526
81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Coman IC
Romanian journal of ophthalmology 2019; 63: 135-141
81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Yadav M
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730
80714 Shortening of Interpupillary Distance after Instillation of Topical Prostaglandin Analogue Eye Drops
Sano I
American Journal of Ophthalmology 2019; 206: 11-16
80652 Topical medical therapy and ocular perfusion pressure in open angle glaucoma: a systematic review and meta-analysis
Rennie G
Current Medical Research and Opinion 2019; 35: 1421-1431
81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Tang W
Medicine 2019; 98: e16597
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Liu Y
Frontiers in pharmacology 2019; 10: 679
80665 Effects of Anti-Glaucoma Prostaglandin Ophthalmic Solutions on Cultured Human Corneal Epithelial Cells
Tong L
Current Eye Research 2019; 44: 856-862
80450 Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness
Okutucu M
Cutaneous and Ocular Toxicology 2019; 38: 196-200
80582 The effect of topical latanoprost on corneal clarity; 1-year prospective study
Sen E
Cutaneous and Ocular Toxicology 2019; 38: 253-257
81367 Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension
Ferro Desideri L
Drugs of Today 2019; 55: 377-384
81381 Effects of the Glaucoma Drugs Latanoprost and Brimonidine on Corneal Temperature
Konieczka K
Translational vision science & technology 2019; 8: 47
81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Xu J
Journal of Controlled Release 2019; 305: 18-28

Issue 20-3

Select Issue